Exane Derivatives’s Vivmark Residential VMRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-599
Closed -$53.9K 846
2022
Q1
$53.9K Hold
599
0.02% 561
2021
Q4
$54.2K Buy
599
+554
+1,231% +$47.7K 0.01% 486
2021
Q3
$3.64K Buy
45
+31
+221% +$2.56K ﹤0.01% 758
2021
Q2
$1.14K Sell
14
-141
-91% -$10.7K ﹤0.01% 861
2021
Q1
$11.1K Hold
155
﹤0.01% 593
2020
Q4
$9.19K Hold
155
﹤0.01% 527
2020
Q3
$7.96K Hold
155
﹤0.01% 480
2020
Q2
$9.12K Sell
155
-2,323
-94% -$144K ﹤0.01% 420
2020
Q1
$153K Buy
+2,478
New +$192K 0.04% 231
2019
Q4
Sell
-2,600
Closed -$221K 693
2019
Q3
$224K Buy
2,600
+1,684
+184% +$138K 0.04% 233
2019
Q2
$69.5K Sell
916
-701
-43% -$53.5K 0.01% 364
2019
Q1
$122K Sell
1,617
-2,633
-62% -$190K 0.02% 273
2018
Q4
$280K Buy
4,250
+2,844
+202% +$191K 0.05% 216
2018
Q3
$91.9K Buy
1,406
+153
+12% +$10.1K 0.02% 327
2018
Q2
$79.9K Buy
1,253
+76
+6% +$4.74K 0.01% 356
2018
Q1
$71.4K Buy
1,177
+100
+9% +$5.94K 0.01% 330
2017
Q4
$68.7K Buy
1,077
+67
+7% +$4.47K 0.01% 320
2017
Q3
$66.6K Buy
1,010
+133
+15% +$8.9K 0.01% 287
2017
Q2
$57.7K Buy
877
+122
+16% +$7.97K 0.01% 307
2017
Q1
$47K Buy
+755
New +$47.2K 0.01% 271

Other funds holding VMRK

Exane Derivatives's VMRK Position: Q2 2022 in Review

Exane Derivatives sold out of Vivmark Residential (VMRK) in Q2 2022, closing a stake of 599 shares — an estimated $53.9K sold.

Exane Derivatives first reported a position in VMRK in Q1 2017 and held it in 20 quarters. The position peaked at $280K in Q4 2018. 618 funds tracked by Wall St. Rank hold VMRK as of Q2 2022.

  • Exane Derivatives reported no remaining Vivmark Residential position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 599 Vivmark Residential shares in Q2 2022, an estimated $53.9K.
  • Exane Derivatives first reported a position in Vivmark Residential in Q1 2017 and held it in 20 quarters.
  • Exane Derivatives's Vivmark Residential position peaked at $280K in Q4 2018.
  • 618 funds tracked by Wall St. Rank held Vivmark Residential as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.